- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
Patent holdings for IPC class C07K 14/705
Total number of patents in this class: 14446
10-year publication summary
|
832
|
917
|
1150
|
1279
|
1365
|
1531
|
1485
|
1394
|
1226
|
549
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19839 |
311 |
| The Trustees of the University of Pennsylvania | 4315 |
310 |
| The Board of Trustees of the Leland Stanford Junior University | 6380 |
201 |
| Memorial Sloan-Kettering Cancer Center | 1913 |
180 |
| Regeneron Pharmaceuticals, Inc. | 4233 |
179 |
| Board of Regents, The University of Texas System | 5754 |
161 |
| Immatics Biotechnologies GmbH | 1154 |
151 |
| Novartis AG | 10883 |
140 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
128 |
| The General Hospital Corporation | 4710 |
90 |
| City of Hope | 982 |
85 |
| Autolus Limited | 252 |
81 |
| Dana-Farber Cancer Institute, Inc. | 2556 |
76 |
| CRISPR Therapeutics AG | 362 |
74 |
| Alpine Immune Sciences, Inc. | 80 |
72 |
| Baylor College of Medicine | 941 |
71 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3365 |
67 |
| Juno Therapeutics, Inc. | 384 |
66 |
| Lentigen Technology, Inc. | 100 |
66 |
| Fred Hutchinson Cancer Center | 438 |
64 |
| Other owners | 11873 |